Table 2: Post-procedure complications.
n: 543 |
% |
||
Early complications |
7 |
1.28 |
|
Hemothorax |
0 |
0 |
|
Pneumothorax |
3 |
0.5 |
|
Hematoma |
3 |
0.5 |
|
Catheter migration |
1 |
0.18 |
|
Late complications |
41 |
7.55 |
|
Catheter-associated infection |
14 |
2.5 |
|
Catheter dysfunction |
6 |
1.2 |
|
Catheter-reservoir disconnection |
1 |
0.18 |
|
Septic embolism |
1 |
0.01 |
|
Reservoir torsion |
4 |
0.7 |
|
Skin erosion |
11 |
2.0 |
|
Venous thrombosis |
4 |
0.7 |
|
Complications by intervention site |
|||
Right |
35 |
6.4 |
|
Left |
13 |
2.3 |
|
Complications by gender |
|||
Male |
21 |
3.8 |
|
Female |
27 |
4.9 |
|
Complications by catheter brand |
|||
Celsite catheter* |
34 |
6.2 |
|
Bard catheter** |
14 |
2.5 |
|
Total complications |
48 |
8.8 |
|
Mortality |
0 |
0 |
*Celsite® ST301V, B. Braun Medical, Boulogne Cedex, France); **Bard catheters (Bard, Utah, USA)